Unclaimed brand
04 April 2022, London – Qinecsa Solutions announced the acquisition of MyMeds&Me Limited (MMM). Qinecsa, a leading provider of pharmacovigilance services and…
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#003345
Cyprus
0, 51, 69
196, 100, 14
100, 26, 0, 73
#AA82E4
Lavender
170, 130, 228
264, 64, 70
25, 43, 0, 11
#003445
Cyprus
0, 52, 69
195, 100, 14
100, 25, 0, 73
My Meds & Me is a brand that specializes in providing an end-to-end pharmacovigilance solution to simplify the capture of adverse event and product quality data, as well as accelerate safety insights. Their innovative Reportum Drug Safety Platform has transformed the pharmacovigilance process in the pharmaceutical industry by offering a proven and scalable SaaS platform used by Pharma & CROs worldwide. My Meds & Me boasts a team of experienced medical and technology experts with deep knowledge in Drug Development and Pharmacovigilance.
Their goal is to drive positive change in the industry and make medicines safer and more efficient. With a focus on problem-solving, innovation, and continuous improvement, My Meds & Me invests in their people and products to deliver the best possible solutions. Partnering with reputable companies like Oracle, Insife, Proact, Amazon Web Services, and Auxita, they strive to create better, safer, and faster experiences for their customers.
Contact My Meds & Me to learn more about their dynamic software product, Reportum, and request a demo
Company type
Privately Held
Year founded
2012
Company size
11-50 employees
Pharmacovigilance case management
Adverse-event intake platforms
Drug safety signal detection
Pharmacovigilance outsourcing
Regulatory safety reporting